Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Caterpillar fungus believed to cure ailments
Scientists discover fungus has anti-inflammatory properties

A new study, published in the journal RNA, has shed light on the “golden worm” or “Tibetan mushroom” thought by locals in Tibet to cure everything from cancer to asthma to erectile dysfunction.

For a Tibetan mushroom to form, a fungus must attach itself to a moth larva burrowed in the soil. It will then slowly consume the host from within, taking over its brain and making the young caterpillar move to position which the fungus can grow and spore again.

The parasite is called cordyceps and produces the chemical cordycepin which scientists now believe has anti-inflammatory properties.

Study co-author Cornelia H. de Moor, of the University of Nottingham, explained: "Inflammation is normally a beneficial response to a wound or infection, but in diseases like asthma it happens too fast and to too high of an extent. When cordycepin is present, it inhibits that response strongly."

The chemical does this in a way not previously seen: at the mRNA stage, where it inhibits polyadenylation. This means it stops swelling at the genetic cellular level - a novel anti-inflammatory approach that could lead to new drugs for cancer, asthma, diabetes, rheumatoid arthritis, and cardiovascular-disease patients who don't respond well to current medications.

However, these new drugs may be a long way off. The science of parasitic fungi is still in its early stages, and no medicine currently available utilises cordycepin as an anti-inflammatory. The only way a patient could gain its benefits would be by consuming wild-harvested mushrooms.

"I can't recommend taking wild-harvested medications," warned de Moor. "Each sample could have a completely different dose, and there are mushrooms where a single bite will kill you."

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
BBC Radio 4 documentary addresses corporate fees

BBC Radio 4's File on 4 Investigates has released a documentary exploring how corporate-owned veterinary practices may be inflating bills to increase profit.

Released on 15 April, 'What's Happening To Your Vet Bills?' revealed the policies which many corporate groups have in place to increase their profits. This included targets and upgrades which veterinary teams are tasked with meeting on a regular basis.

It also features Anrich Vets, an independently-owned practice based in Wigan. Following the case of Staffordshire terrier Benjy, who is diagnosed with a tumour, the documentary shares how the team were able to offer contextualised care and advice to make the procedure as affordable as possible for his owners.

The documentary can be heard on demand on BBC iPlayer.